| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.001 | 1 |